Clearpoint Neuro
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT) (PR Newswire)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
PR Newswire
NEW YORK, May 2, 2024
NEW YORK , May 2, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ClearPoint Neuro, Inc. (NASDAQ: CLPT) on behalf of the company's shareholders. The investigation seeks to determine whether ClearPoint Neuro's directors breached their fiduciary duties in connection with recent corporate actions.
If you are a shareholder of ClearPoint Neuro and are interested in obtaining additional information about your rights and options, please visit us at: https://pjlfirm.com/clearpoint-neuro-inc/
You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.
Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud , breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com . Attorney advertising. Prior results do not guarantee a similar outcome.
View original content to download multimedia: https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-clearpoint-neuro-inc-nasdaq-clpt-302134047.html
SOURCE Purcell & Lefkowitz LLP